Literature DB >> 25601947

Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review.

Chun-Ju Chiang1, San-Lin You2, Chien-Jen Chen3, Ya-Wen Yang1, Wei-Cheng Lo1, Mei-Shu Lai4.   

Abstract

Cancer registration provides core information for cancer surveillance and control. The population-based Taiwan Cancer Registry was implemented in 1979. After the Cancer Control Act was promulgated in 2003, the completeness (97%) and data quality of cancer registry database has achieved at an excellent level. Hospitals with 50 or more beds, which provide outpatient and hospitalized cancer care, are recruited to report 20 items of information on all newly diagnosed cancers to the central registry office (called short-form database). The Taiwan Cancer Registry is organized and funded by the Ministry of Health and Welfare. The National Taiwan University has been contracted to operate the registry and organized an advisory board to standardize definitions of terminology, coding and procedures of the registry's reporting system since 1996. To monitor the cancer care patterns and evaluate the cancer treatment outcomes, central cancer registry has been reformed since 2002 to include detail items of the stage at diagnosis and the first course of treatment (called long-form database). There are 80 hospitals, which count for >90% of total cancer cases, involved in the long-form registration. The Taiwan Cancer Registry has run smoothly for >30 years, which provides essential foundation for academic research and cancer control policy in Taiwan.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Taiwan; cancer registry; data quality; population-based system

Mesh:

Year:  2015        PMID: 25601947     DOI: 10.1093/jjco/hyu211

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  84 in total

1.  Amyloidosis and the risk of cancer: a nationwide population-based study.

Authors:  Vincent Yi-Fong Su; Chia-Jen Liu; Yu-Wen Hu; Wei-Juin Su; Yuh-Min Chen; Shinn-Liang Lai; Tzeng-Ji Chen; Diahn-Warng Perng; Yu-Chin Lee; Cheng-Hwai Tzeng; Kun-Ta Chou
Journal:  Int J Clin Oncol       Date:  2015-06-04       Impact factor: 3.402

2.  Effectiveness of tomotherapy vs linear accelerator image-guided intensity-modulated radiotherapy for localized pharyngeal cancer treated with definitive concurrent chemoradiotherapy: a Taiwanese population-based propensity score-matched analysis.

Authors:  Yao-Ching Wang; Chia-Chin Li; Chun-Ru Chien
Journal:  Br J Radiol       Date:  2018-05-17       Impact factor: 3.039

3.  Forecast of peak attainment and imminent decline after 2017 of oral cancer incidence in men in Taiwan.

Authors:  Jing-Rong Jhuang; Shih-Yung Su; Chun-Ju Chiang; Ya-Wen Yang; Li-Ju Lin; Tsui-Hsia Hsu; Wen-Chung Lee
Journal:  Sci Rep       Date:  2022-04-06       Impact factor: 4.379

4.  Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers might be associated with lung adenocarcinoma risk: a nationwide population-based nested case-control study.

Authors:  Han-Lin Hsu; Chih-Hsin Lee; Chien-Hsin Chen; Jun-Fu Zhan; Szu-Yuan Wu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

5.  Comparison of FDG-PET/CT for Cancer Detection in Populations With Different Risks of Underlying Malignancy.

Authors:  Hung-Pin Chan; Wen-Shan Liu; Wen-Shiung Liou; Chin Hu; Yu-Li Chiu; Nan-Jing Peng
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

6.  Predicting Colon Cancer-Specific Survival for the Asian Population Using National Cancer Registry Data from Taiwan.

Authors:  Han-Ching Chan; Chi-Cheng Huang; Ching-Chieh Huang; Amrita Chattopadhyay; Kuan-Hung Yeh; Wen-Chung Lee; Chun-Ju Chiang; Hsin-Ying Lee; Skye Hung-Chun Cheng; Tzu-Pin Lu
Journal:  Ann Surg Oncol       Date:  2021-08-24       Impact factor: 5.344

7.  Long-Term Survival Effect of the Interval between Postoperative Chemotherapy and Radiotherapy in Patients with Completely Resected Pathological N2 Non-Small-Cell Lung Cancer.

Authors:  Shih-Min Lin; Hsiu-Ying Ku; Che-Yu Hsu; Chih-Liang Wang; Gee-Chen Chang; Cheng-Shyong Chang; Tsang-Wu Liu
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

8.  Association of Primary Treatment Modality for Advanced-Stage Oropharyngeal Squamous Cell Carcinoma With Survival Outcomes.

Authors:  Mu-Hung Tsai; Yung-Jen Cheng; Tzu-Hui Pao; Wei-Ting Hsueh; Helen H W Chen; Yuan-Hua Wu
Journal:  JAMA Netw Open       Date:  2021-06-01

9.  Optimal radiotherapy dose in cervical esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy: A population based study.

Authors:  Chia-Chin Li; Chih-Yi Chen; Ying-Hsiang Chou; Chih-Jen Huang; Hsiu-Ying Ku; Chun-Ru Chien
Journal:  Thorac Cancer       Date:  2021-05-24       Impact factor: 3.500

10.  Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.

Authors:  Szu-Min Peng; Wen-Feng Hsu; Ying-Wei Wang; Li-Ju Lin; Amy Ming-Fang Yen; Li-Sheng Chen; Yi-Chia Lee; Ming-Shiang Wu; Tony Hsiu-Hsi Chen; Han-Mo Chiu
Journal:  Gut       Date:  2020-09-28       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.